000950.SZ
重药控股
SZSE · Healthcare · F 批发零售 · CN
CNY 5.41
−1.28%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 82.3B | 82.4B | 80.6B | 78.4B | 67.8B |
| Cost of Revenue | 76.4B | 76.5B | 74.6B | 72.1B | 62.0B |
| Gross Profit | 5.9B | 5.9B | 6.0B | 6.3B | 5.8B |
| Operating Expenses | |||||
| R&D Expense | 758.8K | 469.7K | 318.6K | 383.3K | 3.2M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 1.7B | 1.7B | 1.6B | 1.5B | 1.3B |
| Selling & Marketing Expense | 2.1B | 2.1B | 2.4B | 2.2B | 2.0B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 4.7B | 4.8B | 5.3B | 5.2B | 4.6B |
| Cost and Expenses | 81.1B | 81.3B | 79.8B | 77.4B | 66.6B |
| Operating Income (EBIT) | 713.4M | 682.9M | 562.6M | 964.9M | 1.4B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 705.8M | 671.9M | 557.5M | 966.3M | 1.5B |
| Income Tax Expense | 158.6M | 150.5M | 155.7M | 236.0M | 309.5M |
| Bottom Line | |||||
| Net Income | 432.2M | 386.7M | 283.0M | 624.6M | 952.3M |
| Earnings from Cont. Ops | 547.2M | 521.3M | 401.8M | 730.3M | 1.2B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 432.2M | 386.7M | 283.0M | 624.6M | 952.3M |
| Per Share | |||||
| Basic EPS | CN¥0.25 | CN¥0.22 | CN¥0.16 | CN¥0.36 | CN¥0.55 |
| Diluted EPS | CN¥0.25 | CN¥0.22 | CN¥0.16 | CN¥0.36 | CN¥0.55 |
| Revenue Per Share | CN¥48.19 | CN¥46.90 | CN¥45.55 | CN¥45.18 | CN¥39.18 |
| Shares | |||||
| Basic Shares Outstanding | 1.7B | 1.8B | 1.8B | 1.7B | 1.7B |
| Diluted Shares Outstanding | 1.7B | 1.8B | 1.8B | 1.7B | 1.7B |
| Profitability Metrics | |||||
| EBITDA | — | 1.0B | 903.0M | 1.3B | 1.7B |
| D&A | — | 334.2M | 340.3M | 295.4M | 264.3M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026